Vivo Capital, LLC Allakos Inc. Transaction History
Vivo Capital, LLC
- $368 Million
- Q1 2025
A detailed history of Vivo Capital, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 765,500 shares of ALLK stock, worth $252,615. This represents 0.05% of its overall portfolio holdings.
Number of Shares
765,500
Previous 2,956,110
74.1%
Holding current value
$252,615
Previous $3.58 Million
95.08%
% of portfolio
0.05%
Previous 0.7%
Shares
4 transactions
Others Institutions Holding ALLK
# of Institutions
67Shares Held
61.7MCall Options Held
71.5KPut Options Held
19.8K-
Bvf Inc San Francisco, CA16.6MShares$5.46 Million0.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.69MShares$2.87 Million0.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.23MShares$2.39 Million0.06% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$2.03 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$1.13 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $28M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...